MedTrace Logo

Home-Based Fluid Status Monitoring in Heart Failure Patients

NCT04013373 · Status: TERMINATED · Type: OBSERVATIONAL · Enrollment: 92

Last updated 2021-08-25

No results posted yet for this study

Summary

This is a prospective, multi-center, single-arm study enrolling adult patients who have been hospitalized for heart failure and subsequently discharged. For the duration of study participation, patients will obtain daily at-home bioimpedance measurements. Heart failure symptoms, medications, and re-hospitalizations will be tracked. Additionally, quality of life questionnaires will be administered at the beginning and end of study participation.

Conditions

Interventions

DEVICE

SOZO Bioimpedance Spectroscopy Device

Bioimpedance spectroscopy measurements for assessment of fluid status

Sponsors & Collaborators

  • ImpediMed Limited

    lead INDUSTRY

Principal Investigators

  • James T Heywood, MD · Scripps Clinic

Eligibility

Min Age
21 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-10-09
Primary Completion
2020-07-30
Completion
2021-07-30
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04013373 on ClinicalTrials.gov